Exploration of the personalized immune checkpoint atlas of plasma cell dyscrasias patients using high-dimensional single-cell analysis
Explore this paper's citation graph
Summary
In-depth personalized data demonstrate mass cytometry as a powerful innovation to discover the systematical immune status in the primary and peripheral tumor microenvironment.
- Type
- article
- Published
- 2020-04-21
- Cited by
- 3
- References
- 65
- Access
- Open access
- OpenAlex
- https://openalex.org/W3016436325
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:216072668
Keywords
Mass cytometry, Immune checkpoint, Immune system, Cancer research, Immunotherapy
References
- Multiplexed mass cytometry profiling of cellular states perturbed by small-molecule regulators
- Targeting the PD-1/PD-L1 axis in multiple myeloma: a dream or a reality?
- Downregulation of myeloma-induced ICOS-L and regulatory T cell generation by lenalidomide and dexamethasone therapy.
- The failure of immune checkpoint blockade in multiple myeloma with PD-1 inhibitors in a phase 1 study
- Lenalidomide Enhances Immune Checkpoint Blockade Induced Immune Response in Multiple Myeloma
- Standardizing immunophenotyping for the Human Immunology Project
- Signalling molecules and cytokine production in T cells of multiple myeloma‐increased abnormalities with advancing stage
- RNA-Seq: a revolutionary tool for transcriptomics
- viSNE enables visualization of high dimensional single-cell data and reveals phenotypic heterogeneity of leukemia
- Computational and analytical challenges in single-cell transcriptomics
- Single-Cell Trajectory Detection Uncovers Progression and Regulatory Coordination in Human B cell Development
- Kidney disease associated with plasma cell dyscrasias.
- Targeting PD1–PDL1 immune checkpoint in plasmacytoid dendritic cell interactions with T cells, natural killer cells and multiple myeloma cells
- Orchestrating immune check-point blockade for cancer immunotherapy in combinations.
- Single Cell Mass Cytometry Adapted to Measurements of the Cell Cycle
- The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody.
- Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum
- Tumour Cell Generation of Inducible Regulatory T-Cells in Multiple Myeloma Is Contact-Dependent and Antigen-Presenting Cell-Independent
- Bone marrow stromal cell-derived exosomes as communicators in drug resistance in multiple myeloma cells.
- Are senescence and exhaustion intertwined or unrelated processes that compromise immunity?
Cited by
- T cell landscape and dynamics in immunoglobulin light chain amyloidosis before and after daratumumab‐based therapy
- Immune checkpoint expression patterns on T cell subsets in light-chain amyloidosis: VISTA, PD-1, and TIGIT as potential therapeutic targets
- Identification of potential biomarkers from amino acid transporter in the activation of hepatic stellate cells via bioinformatics
- MASS CYTOMETRY PUBLICATIONS
Related papers
- Application and utility of mass cytometry in vaccine development
- Human immune system adaptations to simulated microgravity revealed by single-cell mass cytometry
- The total mass, number, and distribution of immune cells in the human body
- Current Progress and Future Perspectives of Immune Checkpoint in Cancer and Infectious Diseases
- Mass Cytometry of the Human Mucosal Immune System Identifies Tissue- and Disease-Associated Immune Subsets.
- The Development, Function, and Plasticity of the Immune Macroenvironment in Cancer
- The Development, Function, and Plasticity of the Immune Macroenvironment in Cancer
- Checkpoint blockade-induced CD8+ T cell differentiation in head and neck cancer responders